Treating Antimicrobial Resistant Infections: A Nano-scale Approach with Big Impacts

Antimicrobial-resistant (AMR) infections are predicted to kill 10 million people each year by 2050—up from 700,000 in 2019—and force 24 million people into extreme poverty as early as 2030. Yet, the pharmaceutical industry has divested from the antibiotic resistance crisis, investing instead in more lucrative types of drugs.

Why I Give to DOVS: Ellen Geishirt

Ellen Geishirt became a patient of UW Health eye specialists after a serious eye infection complicated her recovery from a third corneal transplant in 2015. In late 2020, after an initial donation to the department, …

DOVS Researcher Honored with Emeritus Status

Stacy Meuer, long-time DOVS researcher, has been honored with distinguished researcher emeritus status by the University of Wisconsin-Madison. Barbara Klein, MD, MPH, professor, and Robert Golden, MD, dean of the UW School of Medicine and …